some reading, page-26

The SP is low because of the position that the company finds itself in with regard to capital, which reflects the fact that all has not gone according to plan for the last few years.

Oraline was supposed to hit the ground running and be sold to the company's "extensive law enforcement, military and corrections industry contacts" when Sun Labs was acquired in September 2005, not to mention "800 direct sales customers throughout all 50 US states as well as international representation through agency agreements".

So it's been a long haul, and one that has drained every cent of cash, along with all of the cash received in exchange for the issue of new shares on 21 occasions since acquiring SunLabs product range in late 2005. And of course they haven't actually paid for most of SunLabs yet, this is due next month.

The last half yearly report (28/02/08 - note 11 "Going Concern") siad that they had $500k, and needed to raise capital to carry on. The auditors said that should Note 11 not eventuate then SBN had immediate problems. So the SP got slapped, and rightly so.

We've since found out that they're not going to be able to trade their way out of it, and that they are still cash flow negative, so the SP got slapped again. Again - rightly so.

If the cap raising fails then the final slap could well be fatal.

So that's why the SP is at 1.6c.

SBN need some massive sales agreements, from good payers, to get going.
If there are indeed 800 suppliers in the US, and SBN are supplying them, then judging by the revenue figures in the last update the sales to each customer are so negligible that it will be costing SBN money to supply many of them.

The key is government departments. If they get those they'll be ok, and will prosper Otherwise they're toast.